FDA approves Biogen’s aducanumab
Aducanumab is the first new dementia drug treatment to come to market since 2003.
News & events
News, conferences, events, blogs and updates from across the field of dementia and the work of Alzheimer's Disease International.
Featured news and events
From Plan to Impact report launch
The report launch of From Plan to Impact IV: Progress towards targets of the WHO Global action plan on dementia will take place virtually on 26 May.
Alzheimer’s Association International Conference® (AAIC®)
This year's Alzheimer's Association International Conference (AAIC) will take place in Denver, USA on 26-30 July.
Address: Amsterdam, Netherlands
ADI Council votes on new members, Board appointees
ADI is pleased to welcome 6 new member associations, as well as new members to the ADI board.
Medical and Scientific Advisory Panel (MSAP) meeting
During the 60-minute meeting, the advisory panel discussed ADI's activities over the last year, as well as proposals for future avenues of research, including a working group to explore the impact of COVID-19 as a potential risk factor for accelerating dementia.
ADI Council Meeting of 2021
The ADI Council met on 30 March 2021 to discuss ADI's activities over 2020, new membership applications and more.
ADI attends Western Pacific policy roundtable discussion
The discussions focused on developing a regional policy brief for the promotion, protection and restoration of mental health in older adults, with the inclusion of a focus on dementia awareness and risk reduction.